Back to HBK INVESTMENTS L P HBK INVESTMENTS L P

APLSAPLS
4 quarters

Position history for HBK INVESTMENTS L PHBK INVESTMENTS L P's holdings in APELLIS PHARMACEUTICALS INC

As of its Q1 2026 13F, HBK Investments held 3,550,000 shares of APLS (Apellis Pharmaceuticals), worth $142.8M. APLS was 1.4% of HBK Investments' reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$338,000

Total Shares Change

-14,038

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$41.03
0
2026-Q1
New
3.6M
-
$142.8M1.4%$20.16
69
2019-Q4
Exited
0
-100.0%
$00.0%$29.51
0
2019-Q3
New
14,038
-
$338,0000.0%$24.43
33

Other major holders of APLS: Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used